This federal contract award, SPE2DP16D0009/0020, was issued by the Defense Logistics Agency (DLA) to the prime contractor Glaxosmithkline, LLC. The $312,660.00 firm fixed price delivery order is for the antiviral medication zanamivir. The contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in North Carolina. Glaxosmithkline is a pharmaceutical company that provides vaccines, antivirals, and other products to various U.S. government agencies including the Departments of Defense, Veterans Affairs, and Health and Human Services. This award is associated with a larger indefinite delivery vehicle (IDV) contract Glaxosmithkline holds with the DLA to provide the antiviral medication zanamivir. The company has supported federal disease prevention, immunization, and drug stockpiling initiatives through multiple prime contract and grant awards.